[go: up one dir, main page]

SI9500295B - 17-desoxy-corticosteroid-21-/O/-carboxy acid esters, process for their preparation and medicaments containing them - Google Patents

17-desoxy-corticosteroid-21-/O/-carboxy acid esters, process for their preparation and medicaments containing them Download PDF

Info

Publication number
SI9500295B
SI9500295B SI9500295A SI9500295A SI9500295B SI 9500295 B SI9500295 B SI 9500295B SI 9500295 A SI9500295 A SI 9500295A SI 9500295 A SI9500295 A SI 9500295A SI 9500295 B SI9500295 B SI 9500295B
Authority
SI
Slovenia
Prior art keywords
formula
methyl
hydrogen
compound
salt
Prior art date
Application number
SI9500295A
Other languages
English (en)
Slovenian (sl)
Other versions
SI9500295A (en
Inventor
Ulrich Stache
Hans-Georg Alpermann
Manfred Bohn
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of SI9500295A publication Critical patent/SI9500295A/sl
Publication of SI9500295B publication Critical patent/SI9500295B/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI9500295A 1994-09-20 1995-09-20 17-desoxy-corticosteroid-21-/O/-carboxy acid esters, process for their preparation and medicaments containing them SI9500295B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4433374A DE4433374A1 (de) 1994-09-20 1994-09-20 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
SI9500295A SI9500295A (en) 1996-04-30
SI9500295B true SI9500295B (en) 2001-12-31

Family

ID=6528610

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9500295A SI9500295B (en) 1994-09-20 1995-09-20 17-desoxy-corticosteroid-21-/O/-carboxy acid esters, process for their preparation and medicaments containing them

Country Status (24)

Country Link
US (1) US5824670A (zh)
EP (1) EP0708111B1 (zh)
JP (1) JP3902255B2 (zh)
KR (1) KR100406627B1 (zh)
CN (1) CN1056151C (zh)
AT (1) ATE188480T1 (zh)
AU (1) AU695710B2 (zh)
CA (1) CA2158610C (zh)
CZ (1) CZ288297B6 (zh)
DE (2) DE4433374A1 (zh)
DK (1) DK0708111T3 (zh)
ES (1) ES2140596T3 (zh)
FI (1) FI114708B (zh)
GR (1) GR3032688T3 (zh)
HU (1) HU217438B (zh)
IL (1) IL115331A (zh)
NO (1) NO305210B1 (zh)
NZ (1) NZ280038A (zh)
PL (1) PL186071B1 (zh)
PT (1) PT708111E (zh)
RU (1) RU2161624C2 (zh)
SI (1) SI9500295B (zh)
TW (1) TW424094B (zh)
ZA (1) ZA957877B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012011106A1 (en) * 2010-07-20 2012-01-26 Taro Pharmaceutical Industries Ltd. Process for the preparation of 17-desoxy-corticosteroids
US12209988B2 (en) 2019-05-24 2025-01-28 Electronics And Telecommunications Research Institute Sensor and method of manufacturing the same

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2755292A (en) * 1952-01-21 1956-07-17 Organon Labor Ltd Phenyl propionate of testosterone
US2783226A (en) * 1955-02-03 1957-02-26 Schering Corp Esters of cortical hormones
ES229413A1 (es) * 1956-06-22 1956-11-01 Francisco Vismara S P A UN PROCEDIMIENTO PARA LA PREPARACIoN DE COMPUESTOS ESTEROIDALES QUE CONTENGAN UN GRUPO CEToLICO EN LA CADENA LATERAL
DE1131668B (de) * 1959-07-16 1962-06-20 Leo Ab Verfahren zur Herstellung von Estern von Corticosteroid-Hormonen
CH495969A (de) * 1965-11-09 1970-09-15 Schering Ag Verfahren zur Herstellung neuer 21-Ester von 16a-Methyl-21-hydroxy- 1,4-steroiden
DE2047105C3 (de) * 1970-09-18 1979-02-15 Schering Ag, 1000 Berlin Und 4619 Bergkamen 17-Chlorsteroide und Verfahren zu ihrer Herstellung
US3956349A (en) * 1975-02-18 1976-05-11 Syntex (U.S.A.) Inc. Process for preparing 3-enol ethers of 11β-hydroxy-Δ4 -pregnene-3-ones and derivatives thereof
FR2342738A1 (fr) * 1976-03-02 1977-09-30 Roussel Uclaf Nouveaux derives halogenes de la serie du 16a-methyl pregnane
DE2617655C2 (de) * 1976-04-21 1984-11-08 F. Hoffmann-La Roche & Co Ag, Basel Kortikoide, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE2645104C2 (de) * 1976-10-04 1986-04-24 Schering AG, 1000 Berlin und 4709 Bergkamen 11β-Hydroxy-1,4,8-pregnatrien-3,20-dion-Derivate und Verfahren zu ihrer Herstellung
FR2381065A2 (fr) * 1977-02-22 1978-09-15 Roussel Uclaf Nouveaux derives halogenes de la serie du 16 a-methyl pregnane
US4086254A (en) * 1977-04-13 1978-04-25 The Upjohn Company Photocleavable steroids
LU77457A1 (zh) * 1977-05-31 1979-01-19
US4377573A (en) * 1978-01-06 1983-03-22 Leveen Harry H Method of control of gastrointestinal bleeding
DE2817988A1 (de) * 1978-04-25 1979-11-08 Hoechst Ag Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
DE2920726A1 (de) * 1979-05-18 1980-11-27 Schering Ag Neue kortikoide, ihre herstellung und verwendung
ATE8790T1 (de) * 1981-02-02 1984-08-15 Schering Corporation Aromatische heterocyclische steroidester, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
SE8303031D0 (sv) * 1983-05-30 1983-05-30 Leo Ab Improved steroid esters preparation
US4920114A (en) * 1988-06-28 1990-04-24 Merrell Dow Pharmaceuticals Inc. 19-fluoro- or cyano-21-hydroxyprogesterone derivatives useful as 19-hydroxylase inhibitors
US4910191A (en) * 1988-06-28 1990-03-20 Merrell Dow Pharmaceuticals Inc. 19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors
ZA912235B (en) * 1990-04-02 1991-12-24 Merrell Dow Pharma Haloethyl-substituted steroidal enzyme inhibitors

Also Published As

Publication number Publication date
GR3032688T3 (en) 2000-06-30
HUT72969A (en) 1996-06-28
NZ280038A (en) 1997-03-24
PT708111E (pt) 2000-04-28
IL115331A0 (en) 1995-12-31
CA2158610A1 (en) 1996-03-21
NO305210B1 (no) 1999-04-19
DE4433374A1 (de) 1996-03-21
CZ242595A3 (en) 1996-04-17
NO953695D0 (no) 1995-09-19
NO953695L (no) 1996-03-21
CN1124250A (zh) 1996-06-12
JP3902255B2 (ja) 2007-04-04
SI9500295A (en) 1996-04-30
AU3172895A (en) 1996-04-04
ATE188480T1 (de) 2000-01-15
US5824670A (en) 1998-10-20
HU9502735D0 (en) 1995-11-28
RU2161624C2 (ru) 2001-01-10
DE59507565D1 (de) 2000-02-10
CZ288297B6 (en) 2001-05-16
CA2158610C (en) 2007-07-17
PL310544A1 (en) 1996-04-01
KR100406627B1 (ko) 2004-02-19
FI114708B (fi) 2004-12-15
IL115331A (en) 2002-07-25
DK0708111T3 (da) 2000-06-13
ES2140596T3 (es) 2000-03-01
AU695710B2 (en) 1998-08-20
FI954394L (fi) 1996-03-21
EP0708111B1 (de) 2000-01-05
TW424094B (en) 2001-03-01
JPH0899992A (ja) 1996-04-16
KR960010681A (ko) 1996-04-20
CN1056151C (zh) 2000-09-06
EP0708111A1 (de) 1996-04-24
PL186071B1 (pl) 2003-10-31
FI954394A0 (fi) 1995-09-18
ZA957877B (en) 1996-04-03
HU217438B (hu) 2000-01-28

Similar Documents

Publication Publication Date Title
KR100447096B1 (ko) 바이러스성또는세균성뉴라미니다제의신규한선택적저해제
US4362737A (en) Transdermal carrier materials
KR940005652A (ko) 담즙산 유도체, 이의 제조방법 및 약제로서의 이들 화합물의 용도
JPS5849393A (ja) 合成りん脂質化合物とその製造方法
SE8900828L (sv) Antivirala och immunstimulerande farmaceutiska kompositioner samt foerfarande foer framstaellning av desamma
US4386077A (en) Pharmaceutical composition for oral administration containing cytidine diphosphocholine
SI9500295B (en) 17-desoxy-corticosteroid-21-/O/-carboxy acid esters, process for their preparation and medicaments containing them
FI834702A0 (fi) Nya nitroalifatiska foereningar, deras framstaellningsfoerfarande och anvaendning
GB1285400A (en) Esters of substituted anthranilic acid
SE8900827L (sv) Nya foereningar av salttyp samt foerfarande foer framstaellning av desamma
FI863311A (fi) Farmaceutiska kompositioner innehaollande acylerade fosfolipider.
JP2000143544A (ja) 可溶化剤としてのヒドロキシル化カルボン酸のエステルまたはアミドの使用、該化合物を含有する医薬品調剤および化粧品調剤ならびに食料調製物、およびヒドロキシル化カルボン酸エステル
JPS6328403B2 (zh)
IL72668A0 (en) Benzoic acid derivatives,their preparation and pharmaceutical compositions containing them
JPH01304033A (ja) 二疎水鎖二親水基型界面活性剤
EP0976734A2 (en) Selective inhibitors of viral or bacterial neuraminidase
US2891943A (en) Novel antibiotically active products
US4056672A (en) Polymer prepared by cyanhydrin method
GB1368015A (en) 1-imidazolyl-methanephosphonic acid esters their production and their medicinal use
DE3362246D1 (en) Magnesium salt of chenodeoxycholic acid and ursodeoxycholic acid, the process for its preparation, and therapeutic compositions which contain it as active principle
EP0038512B1 (en) Transdermal carrier materials
JP2505513B2 (ja) アズレン化合物の安定化法
GB1428803A (en) 4-acetamidophenyl esters of aryl-alkane carboxylic acids and a process for their preparation
ES8200103A1 (es) Un procedimiento para la preparacion de una ftalazina
EP0869817A2 (de) Kovalente lipid-phosphonocarbonsäure-konjugate und ihre anwendung als antivirale arzneimittel

Legal Events

Date Code Title Description
IF Valid on the event date